| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
122,527 |
103,935 |
$20.53M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
49,087 |
41,555 |
$7.90M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,880 |
21,423 |
$3.94M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
10,605 |
9,486 |
$1.94M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,451 |
9,203 |
$1.87M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,677 |
5,883 |
$1.79M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,453 |
8,290 |
$1.51M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,792 |
5,433 |
$1000K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,333 |
3,884 |
$977K |
| G0378 |
Hospital observation service, per hour |
6,273 |
3,327 |
$774K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,487 |
1,343 |
$742K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,982 |
3,449 |
$671K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18,592 |
16,539 |
$431K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,984 |
8,451 |
$339K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,690 |
2,442 |
$296K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,391 |
1,275 |
$242K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
681 |
614 |
$224K |
| 10060 |
|
1,519 |
1,336 |
$210K |
| 12001 |
|
759 |
704 |
$167K |
| 93971 |
|
1,753 |
1,568 |
$147K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
281 |
261 |
$141K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,655 |
1,113 |
$132K |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
1,403 |
204 |
$117K |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
1,540 |
216 |
$115K |
| 80053 |
Comprehensive metabolic panel |
36,666 |
30,218 |
$109K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,200 |
1,513 |
$107K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
969 |
894 |
$104K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,438 |
1,325 |
$103K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,385 |
1,278 |
$102K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,339 |
2,991 |
$101K |
| 97163 |
|
926 |
835 |
$99K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
494 |
456 |
$94K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
148 |
128 |
$90K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
22,335 |
18,293 |
$88K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
141 |
135 |
$77K |
| 71046 |
Radiologic examination, chest; 2 views |
18,398 |
16,477 |
$74K |
| 12011 |
|
319 |
292 |
$69K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
684 |
92 |
$68K |
| 76801 |
|
1,826 |
1,616 |
$66K |
| 76830 |
Ultrasound, transvaginal |
1,007 |
938 |
$66K |
| 70491 |
|
292 |
275 |
$59K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
31,355 |
26,324 |
$58K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,523 |
7,652 |
$57K |
| 83880 |
|
8,277 |
6,948 |
$55K |
| 71250 |
|
945 |
853 |
$53K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
693 |
644 |
$53K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,260 |
1,220 |
$53K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
731 |
680 |
$50K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,879 |
20,790 |
$45K |
| 71045 |
Radiologic examination, chest; single view |
21,697 |
18,516 |
$44K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,814 |
2,442 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,922 |
12,635 |
$37K |
| 12002 |
|
155 |
146 |
$35K |
| 72131 |
|
681 |
629 |
$33K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
131 |
118 |
$31K |
| 85027 |
|
59,454 |
46,538 |
$31K |
| 74174 |
|
133 |
121 |
$30K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
29 |
26 |
$28K |
| 84484 |
|
22,690 |
17,093 |
$27K |
| 87040 |
|
4,438 |
3,578 |
$26K |
| 90715 |
|
1,646 |
1,526 |
$26K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,494 |
1,406 |
$25K |
| 76642 |
|
223 |
205 |
$25K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
921 |
433 |
$24K |
| 70486 |
|
659 |
613 |
$24K |
| 85379 |
|
6,057 |
5,401 |
$23K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,166 |
1,036 |
$23K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,175 |
13,424 |
$22K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
581 |
523 |
$18K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
242 |
196 |
$18K |
| 73030 |
|
3,254 |
2,831 |
$18K |
| 93970 |
|
121 |
113 |
$15K |
| 80076 |
|
7,471 |
6,568 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
24,084 |
14,329 |
$14K |
| 29125 |
|
104 |
95 |
$14K |
| 72110 |
|
1,183 |
1,036 |
$13K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
41 |
40 |
$12K |
| 74018 |
|
1,930 |
1,726 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
52 |
48 |
$10K |
| 81001 |
|
32,706 |
27,933 |
$9K |
| 73564 |
|
2,727 |
2,288 |
$9K |
| 73502 |
|
1,458 |
1,295 |
$8K |
| 73610 |
|
3,796 |
3,377 |
$8K |
| 97116 |
|
362 |
234 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
21,059 |
16,428 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,496 |
7,360 |
$8K |
| 73130 |
|
3,351 |
2,944 |
$8K |
| 73630 |
|
4,060 |
3,549 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
497 |
149 |
$7K |
| 80051 |
|
2,780 |
2,289 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
36 |
28 |
$6K |
| 83605 |
|
4,900 |
4,112 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,112 |
2,791 |
$6K |
| 82565 |
|
3,846 |
3,204 |
$6K |
| 72100 |
|
1,129 |
1,038 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,879 |
1,663 |
$5K |
| 73562 |
|
1,594 |
1,340 |
$5K |
| 81025 |
|
25,054 |
21,827 |
$5K |
| 73110 |
|
2,254 |
1,994 |
$5K |
| 96368 |
|
128 |
120 |
$5K |
| 83690 |
|
18,987 |
16,145 |
$5K |
| 83735 |
|
20,194 |
16,932 |
$5K |
| 70498 |
|
41 |
37 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,661 |
6,427 |
$4K |
| 97166 |
|
55 |
49 |
$4K |
| 84702 |
|
5,034 |
4,293 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,860 |
905 |
$4K |
| 80061 |
Lipid panel |
1,305 |
1,174 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31,825 |
26,961 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,420 |
11,871 |
$3K |
| 81003 |
|
16,015 |
14,045 |
$3K |
| 73080 |
|
1,027 |
936 |
$3K |
| 85610 |
|
8,007 |
6,775 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,199 |
5,402 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,559 |
1,148 |
$3K |
| 76870 |
|
33 |
28 |
$3K |
| 84703 |
|
6,454 |
5,806 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,352 |
2,092 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
8,409 |
7,545 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,537 |
3,844 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
24,769 |
22,936 |
$2K |
| 72141 |
|
14 |
12 |
$2K |
| 96376 |
|
2,851 |
2,404 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,014 |
2,657 |
$2K |
| 87070 |
|
12,643 |
11,720 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,646 |
13,586 |
$2K |
| 73590 |
|
819 |
708 |
$2K |
| 73140 |
|
976 |
887 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
22,938 |
21,185 |
$1K |
| 82553 |
|
359 |
219 |
$1K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
12 |
$1K |
| 73700 |
|
14 |
13 |
$1K |
| G0176 |
Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) |
77 |
25 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,481 |
5,887 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,981 |
2,529 |
$1K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
5,514 |
5,003 |
$1K |
| 72128 |
|
41 |
37 |
$1K |
| 87210 |
|
8,169 |
6,472 |
$1K |
| 85730 |
|
5,155 |
4,443 |
$1K |
| 74022 |
|
206 |
179 |
$965.09 |
| 82550 |
|
2,418 |
1,980 |
$959.11 |
| 82947 |
|
2,778 |
2,294 |
$926.59 |
| 86850 |
|
1,353 |
1,196 |
$914.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
76 |
61 |
$881.15 |
| 84520 |
|
2,941 |
2,406 |
$823.31 |
| 73090 |
|
512 |
475 |
$696.35 |
| 86900 |
|
1,971 |
1,759 |
$670.46 |
| 94644 |
|
88 |
72 |
$666.45 |
| 74019 |
|
119 |
98 |
$578.38 |
| 77065 |
Tomosynthesis, mammo |
26 |
24 |
$552.20 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
75 |
65 |
$539.17 |
| 77066 |
Tomosynthesis, mammo |
26 |
25 |
$507.17 |
| 88304 |
|
625 |
569 |
$506.90 |
| 84100 |
|
1,442 |
1,126 |
$496.41 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,016 |
5,379 |
$477.11 |
| 72050 |
|
12 |
12 |
$456.28 |
| 71101 |
|
142 |
121 |
$408.51 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
40 |
39 |
$394.06 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,865 |
3,286 |
$378.70 |
| 86901 |
|
1,971 |
1,759 |
$378.40 |
| 72040 |
|
101 |
95 |
$371.90 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,458 |
1,052 |
$371.80 |
| 87807 |
|
5,584 |
5,249 |
$309.21 |
| 73552 |
|
67 |
60 |
$295.06 |
| 87077 |
|
1,695 |
1,469 |
$290.24 |
| 87186 |
|
2,839 |
2,453 |
$280.99 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,804 |
3,115 |
$248.52 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
53 |
40 |
$226.52 |
| 87205 |
|
1,126 |
954 |
$223.86 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,452 |
2,049 |
$218.76 |
| 73560 |
|
43 |
37 |
$182.81 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,186 |
987 |
$182.30 |
| 76000 |
|
62 |
55 |
$180.94 |
| 86140 |
|
163 |
153 |
$176.13 |
| J2060 |
Injection, lorazepam, 2 mg |
1,698 |
1,312 |
$140.46 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
717 |
638 |
$137.18 |
| J1815 |
Injection, insulin, per 5 units |
2,106 |
1,100 |
$129.79 |
| 82248 |
|
573 |
496 |
$129.41 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,733 |
1,456 |
$123.76 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,846 |
1,507 |
$109.83 |
| 84439 |
|
44 |
37 |
$97.57 |
| 80069 |
|
21 |
14 |
$84.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,186 |
892 |
$75.20 |
| 82010 |
|
373 |
324 |
$71.22 |
| 73060 |
|
13 |
12 |
$64.25 |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,806 |
3,774 |
$60.55 |
| J1630 |
Injection, haloperidol, up to 5 mg |
485 |
375 |
$44.89 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,071 |
896 |
$44.72 |
| J2704 |
Injection, propofol, 10 mg |
1,523 |
1,219 |
$35.55 |
| 87088 |
|
438 |
378 |
$23.67 |
| 84132 |
|
88 |
77 |
$21.68 |
| J7510 |
Prednisolone oral, per 5 mg |
1,029 |
975 |
$20.94 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
629 |
399 |
$19.49 |
| 87147 |
|
358 |
343 |
$18.73 |
| 82272 |
|
103 |
92 |
$17.99 |
| 86308 |
|
102 |
99 |
$14.52 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,540 |
2,198 |
$14.30 |
| J3480 |
Injection, potassium chloride, per 2 meq |
138 |
114 |
$12.70 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
150 |
102 |
$6.91 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
576 |
525 |
$6.87 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
15 |
12 |
$2.74 |
| C9113 |
Injection, pantoprazole sodium, per vial |
17 |
15 |
$1.38 |
| 85018 |
|
14 |
14 |
$0.48 |
| 85014 |
|
14 |
14 |
$0.48 |
| J3535 |
Drug administered through a metered dose inhaler |
313 |
248 |
$0.00 |
| J3490 |
Unclassified drugs |
2,315 |
1,996 |
$0.00 |
| A9270 |
Non-covered item or service |
5,300 |
2,125 |
$0.00 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
129 |
106 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
101 |
50 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
413 |
252 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
168 |
165 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
28 |
14 |
$0.00 |
| 73660 |
|
13 |
13 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
224 |
197 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
519 |
480 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
245 |
174 |
$0.00 |
| 72070 |
|
31 |
29 |
$0.00 |
| 88312 |
|
17 |
16 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
13 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
134 |
81 |
$0.00 |
| C1776 |
Joint device (implantable) |
17 |
12 |
$0.00 |